PROFESSOR DAE KIM
MBChB, BDS, MSc, FRCS (Orl-HNS), PhD
Professor Kim is one of the UK's leading Head and Neck surgeons, dual qualified in both Medicine and Dentistry.
Area of expertise
- Thyroid & Parathyroid Surgery
- Minimally Invasive & Key Hole Surgery
- Specialist Head & Neck Surgery
- Head & Neck oncology
- Hearing Problems & Infections
- Voice Problems & Disorders
- Throat & Swallowing problems
- Sinusitis & Sinus surgery
- Sleep Disorders & Snoring
Current Employment
Hon. Senior Lecturer, St George’s University of London
Hon. Professor, Faculty of Science, University of Portsmouth
Hon. Senior Lecturer in Surgery, CRUK Cancer Centre, University of Southampton
National Institute of Health Research (NIHR) Head & Neck Cancer CSG SLT Subgroup Committee
Specialist Advisor, Interventional Procedures, National Institute for Health & Care
Training
Qualifying in Medicine from Edinburgh University in 1995, Mr Dae Kim subsequently trained at Edinburgh and Cambridge teaching hospitals. In 2009, after completing a General ENT surgery program within the West Midlands, he was awarded the Specialist Training Certificate in Otolaryngology, and is on the GMC Specialist Register.
Mr Kim underwent an Advanced Fellowship in both Head & Neck Oncology and Endocrine Surgery at the Toronto General Hospital, the Mount Sinai Hospital and the Princess Margaret Cancer Centre (Toronto, Canada) under the tutelage of the world’s most respected surgeons (including Professor Gullane, past-President of the American Head & Neck Society) and oncologists. Having also worked with Professor Franklyn (President of The British Thyroid Association) and Professor John Watkinson (Past President of The British Association of Endocrine and Thyroid Surgeons), Professor Kim has extensive knowledge and experience in Thyroid & Parathyroid surgery.
In 2012, Professor Kim was awarded several prestigious Surgical Training Grants (HCA Foundation, Peel Trust) and became a Winston Churchill Travelling Fellow to complete a highly unique training in ‘Key-Hole’ and Robotic Head and Neck and Thyroid Surgery in the USA with Professor David Terris, Italy with Professor Paulo Miccoli, and in Seoul, Korea with Professor Chung. These unique skills enables him to act as a Specialist Advisor to the National Institute for Health Excellence (NICE) in Key-Hole Thyroid & Parathyroid Surgery. Further, he is employing these techniques to establish a National Centre for Minimally Invasive (Key-Hole) and Robotic Head & Neck Surgery in London, based at St George’s Hospital.
Professor Kim has a strong commitment to research. He was a research fellow at the Harvard Medical School and completed a PhD doctorate research degree (under Professor Franklyn, President of the British Thyroid Association and Professor Watkinson, President of The British Association of Endocrine Surgeons and the British Association of Head & Neck Surgeons), examining the molecular basis of both thyroid and head & neck cancers, for which he was awarded the prestigious ‘Syme Medal’ by the Royal College of Surgeons.
Through his research activities, Professor Kim has developed strong and ongoing links with various departments, within the world famous MD Anderson Cancer Centre, Princess Margaret Cancer Centre and Harvard University Cancer Centre. Presently, he is part of the Thyroid Research team within the Targeted Therapy Group at the world famous Institute of Cancer Research, London.
As testaments to his strive for excellence, he has been awarded with multiple research grants and numerous national and international prizes from the American Thyroid Association, British Association of Endocrine and Thyroid Surgeons, Otolaryngological Research Society and the Royal College of Surgeons. He has authored peer-reviewed publications in many prestigious international journals, and several specialist surgical book chapters including the world renowned Textbook: ‘ The Surgery of the Thyroid and Parathyroid Glands’, edited by Professor Greg Randolph of Massachusetts General Hospital & Harvard University, Boston, USA.
Professor Kim is currently a Consultant ENT & Thyroid Surgeon at St George’s University Hospital, London. He is a member of both the Multidisciplinary Head & Neck Cancer Team and the Multidisciplinary Thyroid Team.
Prizes
The British Journal of Surgery Prize: British Association of Endocrine & Thyroid Surgeons: Awarded for best research paper and presentation (2014)
University College London & Sethia Chitra Medal for Education & Innovation: Course in Robotic and Minimally-invasive ENT/Head & Neck Surgery, UCLH, London (2013)
The Winston Churchill Trust award: 2012 Churchill Fellow - Training in Robotic & Endoscopic thyroid and neck surgery with Professor Chung, Institute of Minimally Invasive & Robotic Surgery, Yonsei University, Seoul, Korea.
HCA International Foundation Training Scholarship Award: Da Vinci robotic & Endoscopic training in Head & Neck Surgery (2012)
Dowager Countess Eleanor Peel Trust Fellowship Award: Da Vinci Robotic & Endoscopic training in Thyroid Surgery (2012)
The Syme Medal for Research: Royal College of Surgeons of Edinburgh: Awarded for Best research Thesis leading to a higher degree (2008)
The British Journal of Surgery Prize: British Association of Endocrine & Thyroid Surgeons: Awarded for best research paper and presentation (2008)
The British Association of Endocrine & Thyroid Surgeons Travelling Fellowship (2011)
Xomed-Treace Basic Science Research prize (Otolaryngological Research Society): Awarded for best research thesis leading to a higher degree (2006)
Philip Stell Research Prize, (Otolaryngological Research Society): Awarded for best research paper and presentation (2005)
American Thyroid Association prize for basic science research: Awarded at the 76th ATA annual scientific meeting, Vancouver, Canada (2004)
CLINICAL & SCIENTIFIC RESEARCH
Professor Kim has a strong commitment to research. He was a research fellow at the Harvard Medical School and completed a PhD doctorate research degree (under Professor Franklyn, Past-President of the British Thyroid Association and Professor Watkinson, President of The British Association of Endocrine Surgeons), examining the molecular basis of both thyroid and head & neck cancers, for which he was awarded the prestigious ‘Syme Medal’ by the Royal College of Surgeons.
During his PhD Doctorate, Prof Kim examined the important carcinogenic mechanisms involved in thyroid and head & neck cancers with a view to identifying novel diagnostic markers and therapeutic targets. He undertook a rigorous scientific study of the role of a novel cancer gene known as PTTG in thyroid and head & neck cancers. PTTG is a multifunctional oncogene shown to be expressed highly in many human cancers, particularly in aggressive tumours, and is predictive of poor patient outcome.
Following this, a period of post-doctoral research as a Clinical Lecturer in ENT Surgery, helped to maintain an ongoing active research program. To enable progression towards an academic career in medicine he subsequently submitted for and was shortlisted for the final-stage interviews for the both the CRUK and MRC Clinician Scientist Fellowships in 2009. As testaments to his strive for excellence, Prof Kim has been awarded with multiple research grants and numerous national and international prizes from the American Thyroid Association, British Association of Endocrine and Thyroid Surgeons, Otolaryngological Research Society and the Royal College of Surgeons. He has authored over 40 peer-reviewed publication, many in prestigious international journals, and several specialist surgical book chapters including the world renowned Textbook: ‘The Surgery of the Thyroid and Parathyroid Glands’, edited by Professor Greg Randolph of Massachusetts General Hospital & Harvard University, Boston, USA.
Presently, Prof Kim supervises a MSc student examining the clinical benefits of minimally-invasive thyroid and parathyroid surgery and an MRC-funded PhD Clinical Research Fellow investigating the role integrin signaling and dysregulated cell metabolism in head & neck and thyroid cancers. Further, he is a core member of a scientific research group, based at the Institute of Cancer Research (London), exploring the role of new and experimental targeted therapy and immunotherapy agents for the treatment of advanced thyroid cancers.